Isolation and Identification of Cancer Stem Cells in Human Gliomas

LI Guang-hui,WANG Dong-lin,CHEN Zheng-tang,YIN Chang-lin,JI Hua,L(U) Sheng-qing

DOI: https://doi.org/10.3969/j.issn.1673-5269.2007.13.004

2007-01-01

Abstract:OBJECTIVE: To isolate and identificate the brain tumor stem cells (BTSCs) within human gliomas tissue in vitro. METHODS: By switching primary human glioblastoma cells into a defined serum-free neural stem cells medium, glioblastoma spheres were isolated. By limiting dilution assay, secondary spheres forming assay, flow cytometry assay and so on, BTSCs were identificated. RESULTS: Glioblastoma spheres consisted of BTSCs expressing CD133 and nestin but no GFAP and MAP2, and a few BTSCs expressed MBP. The percentage of CD133+ cell in 3 cases of primary cultured glioma cells were 7.4%, 2.8% and 4.2%. About 1% cells in primary cultured glioma cells generated free-floating glioblastoma spheres and 100 cells of primary tumor spheres generated 6.07±2.15 secondary glioma spheres expressing CD133 and Nestin. Most cells produced from BTSC spheres expressed GFAP, and a few expressed MAP2 and MBP. Glioma BTSCs cultured in serum-free neural stem cells medium showed a lower degree of cell proliferation than primary glioma cells cultured in medium with 10% FBS. BTSCs had stronger capable of tumor initiation in nude mice than primary cultured glioma cells. CONCLUSIONS: CD133+ BTSCs can be isolated from primary cultured glioma cells by cultured in serum-free neural stem cells medium. BTSCs express CD133 antigen and have characteristics of cancer stem cells.